@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns3:include . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:47:30.956533"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377; prov:wasDerivedFrom . rdf:OBJECT rdfs:label "dexamethasone , vitamin D , tocilizumab and sarilumab , chloroquine , hydroxychloroquine , azithromycin , adalimumab and tetrandrine ," . rdf:OBJECT-POSITION rdfs:label "(41, 47)" . rdf:PREDICATE rdfs:label "including" . rdf:PREDICATE-POSITION rdfs:label "105" . rdf:SUBJECT rdfs:label "the potential Treg-boosting effect of" . rdf:SUBJECT-POSITION rdfs:label "(41, 47)" . rdf:Statement rdfs:label "Furthermore, the potential Treg-boosting effect of therapeutic agents used in the treatment of COVID-19, including dexamethasone, vitamin D, tocilizumab and sarilumab, chloroquine, hydroxychloroquine, azithromycin, adalimumab and tetrandrine, is discussed." . rdfs:ABSTRACT-UID ns1:50 "mjrr9vvj" . rdfs:TRIPLE-UID ns2:mjrr9vvj-TRIPLE-ABSTRACT-3 "mjrr9vvj-TRIPLE-ABSTRACT-3" . rdfs:label "chloroquine" . rdfs:label "effect" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "c3NoLXJzYSBBQUFBQjNOemFDMXljMkVBQUFBREFRQUJBQUFCZ1FDZERUMW1DbmR0T21pNm16VDhyMmI2QVRYZ0I0d1ExWTZUU3NtN2xNblVLWll0REpuSHkzRnI3YjJJUytJZkRBRmxTYVJFbkR4bnJFNWF0QUw0TzdlZ0RrUDlqSHBaNUJlWFhhL1RMOUFKVzRKVVlSRm1OZER3am4xMndsNWVFK20wUkFZanpzejZtQzd4bER6aEFvY2Rrb2VCWXJzbUZZTlVRaUVNdmtNSXY5SU5nNVgzeTU0VWJzVTRwTzExclpNekpocm15ajVhZkE5bmd5ZnBFR0dJc0hTQzJyekRrb2VtVDZXZitVeTBQVHFSbGZGWk1jbG5iMC9CZ2t4Qk9ydVJacm85WFNOMWhFWDNQNTNsSGlGZld6UGExVDZBYjZXaXl4RTF5djNldHlPbXRkN2VWZ2I1eFpOYjNFekhKNFpmN1AvYVB2dVFFdGJzY2NkODJMNzAwSTZPMFdLUDVIVTNrQ01iYXczOVJONGZYYWkyMVdPK2NwODFCV2VvQWk4Yzd2OXQvZTdnYWNKYmJmVFNBQjhZeWs5T0QwWm5OM3ZaRW1TSHMxTTdhVk5QTjhVM3o4d095NEtXYVVRK0FkN1JIMnBDa0NZSk42YUcwL3VPS3d1VXB1NDVIN3FJWUJOSWxpTFRRN2U5a2Y0cWhBYVZ1SEhzc0x6cU1QSmpkYkU9IGF0d2lsdEBMQVBUT1AtRjNMTFJCS1IK"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }